IBNSINA PHARMA
ISPH

EGX

Current Price
EGP
EGP (%)
Price Upon Recommendation
8.00 EGP
Target Price from Recommendation

9.20 EGP

+15.00%
Holding Period

From 1 to 3 months

Final Recommendation

Buy stock at the current price

Valid Until

April 15, 2025 at 8:33:32 PM

Risk Assessment

Medium

Confidence Score

85.00%

Potential Growth

15.00%

Investment Reason

Ibnsina Pharma has demonstrated robust financial performance with significant revenue and profit growth in recent periods. The company's strategic positioning in Egypt's pharmaceutical distribution sector, coupled with favorable economic conditions, suggests potential for continued growth.

Overview
Recent Performance

Over the past year, Ibnsina Pharma's stock price has increased by approximately 166.67%, reflecting strong market confidence.

Economic Factors

Egypt's growing population and increasing demand for healthcare services provide a favorable environment for pharmaceutical distributors like Ibnsina Pharma.

Competitive Positioning

As a leading pharmaceutical distributor in Egypt, Ibnsina Pharma serves both private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and healthcare institutions.

Analysis Summary

Ibnsina Pharma's strong financial performance, strategic market position, and favorable economic conditions support a positive outlook for the stock.

Key Points
  • Strong financial growth with increasing revenues and profits.
  • Leading position in Egypt's pharmaceutical distribution sector.
  • Favorable economic conditions supporting healthcare expansion.
  • Estimated 15% growth potential with a target price of EGP 9.20.
Recommendations